Ozdemir FN - Search Results

1

The effect of simvastatin on panel-reactive antibody and crossmatch positivity.

Ozdemir FN, Sezer S, Turan M, Colak T, Arat Z, Gülmüş S, Haberal M. Ozdemir FN, et al. Transplant Proc. 2001 Aug;33(5):2842-3. doi: 10.1016/s0041-1345(01)02213-8. Transplant Proc. 2001. PMID: 11498182 Clinical Trial. No abstract available.

2

Beneficial effect of plasmapheresis on the outcome of transplant patients.

Haberal M, Ozdemir FN, Kaya S, Bilgin N. Haberal M, et al. Among authors: ozdemir fn. Transplant Proc. 1996 Aug;28(4):2336. Transplant Proc. 1996. PMID: 8769243 No abstract available.

3

Comparison of panel reactive antibody levels with clinical and laboratory parameters in end-stage renal disease patients.

Sezer S, Ozdemir FN, Turan M, Güz G, Haberal A, Kaya S, Bilgin N. Sezer S, et al. Among authors: ozdemir fn. Transplant Proc. 1998 May;30(3):844-5. doi: 10.1016/s0041-1345(98)00072-4. Transplant Proc. 1998. PMID: 9595122 No abstract available.

4

Factors influencing response to hepatitis B virus vaccination in hemodialysis patients.

Sezer S, Ozdemir FN, Güz G, Arat Z, Colak T, Sengul S, Turan M, Haberal A, Erdal R. Sezer S, et al. Among authors: ozdemir fn. Transplant Proc. 2000 May;32(3):607-8. doi: 10.1016/s0041-1345(00)00914-3. Transplant Proc. 2000. PMID: 10812136 No abstract available.

5

Is hepatitis C virus infection a risk factor for panel-reactive antibody positivity?

Ozdemir FN, Sezer S, Güz G, Arat Z, Turan M, Haberal M. Ozdemir FN, et al. Transpl Int. 2000;13 Suppl 1:S31-3. doi: 10.1007/s001470050270. Transpl Int. 2000. PMID: 11111957

6

Ferritin levels can be a good predictor for HCV viremia in potential renal transplant candidates.

Sezer S, Ozdemir FN, Güz G, Ozdemir BH, Sengül S, Arat Z, Turan M, Demirhan B, Haberal M. Sezer S, et al. Among authors: ozdemir bh, ozdemir fn. Transplant Proc. 2001 Aug;33(5):2796-8. doi: 10.1016/s0041-1345(01)02194-7. Transplant Proc. 2001. PMID: 11498163 No abstract available.

7

Significance of diagnostic procedures for renal transplant graft function.

Ozdemir FN, Akçay AT, Ozdemir BH, Turan M, Demirhan B, Colak T, Arat Z, Haberal M. Ozdemir FN, et al. Among authors: ozdemir bh. Transplant Proc. 2002 Sep;34(6):2096-8. doi: 10.1016/s0041-1345(02)02866-x. Transplant Proc. 2002. PMID: 12270328 No abstract available.

8

Influence of recipient family history of atherosclerosis of renal allograft outcome.

Ozdemir FN, Cantürk F, Colak T, Sezer S, Agca E, Haberal M. Ozdemir FN, et al. Transplant Proc. 2003 Nov;35(7):2602-4. doi: 10.1016/j.transproceed.2003.08.047. Transplant Proc. 2003. PMID: 14612035 No abstract available.

9

Do serum albumin and aminotransferase levels predict renal graft outcome: a 5-year follow-up.

Sezer S, Ozdemir FN, Külah E, Colak T, Turan M, Haberal M. Sezer S, et al. Among authors: ozdemir fn. Transplant Proc. 2003 Nov;35(7):2607-8. doi: 10.1016/j.transproceed.2003.09.080. Transplant Proc. 2003. PMID: 14612037 No abstract available.

10

Assessment of risk factors for chronic allograft nephropathy in renal transplant patients.

Sezer S, Ozdemir FN, Agca E, Colak T, Arat Z, Haberal M. Sezer S, et al. Among authors: ozdemir fn. Transplant Proc. 2003 Nov;35(7):2634-6. doi: 10.1016/j.transproceed.2003.08.046. Transplant Proc. 2003. PMID: 14612048 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters